248 related articles for article (PubMed ID: 19415995)
1. Illness perception in patients with differentiated epithelial cell thyroid cancer.
Hirsch D; Ginat M; Levy S; Benbassat C; Weinstein R; Tsvetov G; Singer J; Shraga-Slutzky I; Grozinski-Glasberg S; Mansiterski Y; Shimon I; Reicher-Atir R
Thyroid; 2009 May; 19(5):459-65. PubMed ID: 19415995
[TBL] [Abstract][Full Text] [Related]
2. An element of the art of medicine.
Emerson CH
Thyroid; 2009 May; 19(5):429-30. PubMed ID: 19415990
[No Abstract] [Full Text] [Related]
3. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
4. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
5. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
7. Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma.
Giusti M; Melle G; Fenocchio M; Mortara L; Cecoli F; Caorsi V; Ferone D; Minuto F; Rasore E
J Zhejiang Univ Sci B; 2011 Mar; 12(3):163-73. PubMed ID: 21370500
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
9. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract][Full Text] [Related]
10. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
11. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
Lubitz CC; De Gregorio L; Fingeret AL; Economopoulos KP; Termezawi D; Hassan M; Parangi S; Stephen AE; Halpern EF; Donelan K; Swan JS
Thyroid; 2017 Feb; 27(2):197-206. PubMed ID: 27824301
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.
Almeida JP; Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):342-6. PubMed ID: 19380354
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns of aging Americans with differentiated thyroid cancer.
Park HS; Roman SA; Sosa JA
Cancer; 2010 Jan; 116(1):20-30. PubMed ID: 19908255
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and anxiety in adolescents with differentiated thyroid cancer.
Oren A; Benoit MA; Murphy A; Schulte F; Hamilton J
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1933-7. PubMed ID: 22791758
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
17. High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer.
Roerink SH; de Ridder M; Prins J; Huijbers A; de Wilt HJ; Marres H; Repping-Wuts H; Stikkelbroeck NM; Timmers HJ; Hermus AR; Netea-Maier RT
Acta Oncol; 2013 Jan; 52(1):128-37. PubMed ID: 23101467
[TBL] [Abstract][Full Text] [Related]
18. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
[TBL] [Abstract][Full Text] [Related]
19. Anxiety and Fear of Recurrence Despite a Good Prognosis: An Interview Study with Differentiated Thyroid Cancer Patients.
Hedman C; Strang P; Djärv T; Widberg I; Lundgren CI
Thyroid; 2017 Nov; 27(11):1417-1423. PubMed ID: 28874092
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
